🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate bioequivalence of a 2.5 mg saxagliptin/1000 mg metformin (gl...
Status
Completed
Location
Mds Pharma Services
Start Date
2009-06
Trial ID
NCT00897390
Treatments Being Tested
The primary objective of this study is to assess the pharmacokinetic parame...
Status
Completed
Location
Research Site
Start Date
2013-02
Trial ID
NCT01755494
The purpose of this study is to demonstrate bioequivalence (BE) of a 5 mg s...
Status
Completed
Location
Ppd Development, Lp
Start Date
2009-11
Trial ID
NCT01192139
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics of Saxaglipti...
Status
Terminated
Location
Osborne Research Center
Start Date
2012-09
Trial ID
NCT01525225
To demonstrate bioequivalence of a 2.5 mg saxagliptin/850 mg metformin fixe...
Status
Completed
Location
PPD Development, LP
Start Date
2010-02
Trial ID
NCT01068743
Treatments Being Tested
To demonstrate bioequivalence of a 2.5 mg saxagliptin/500 mg metformin (glu...
Status
Completed
Location
Mds Pharma Services
Start Date
2009-06
Trial ID
NCT00899470
The purpose of this study is to demonstrate bioequivalence (BE) of a 5 mg s...
Status
Completed
Location
PPD Development, LP
Start Date
2009-11
Trial ID
NCT01192152
Treatments Being Tested
To demonstrate the bioequivalence of a 2.5-mg saxagliptin/500-mg metformin ...
Status
Completed
Location
Ppd Development, Lp
Start Date
2010-03
Trial ID
NCT01068717
In this integrated, Phase I study, the safety, tolerability, food effect, a...
Status
Completed
Location
Research Site
Start Date
2017-05-25
Trial ID
NCT03138356
Treatments Being Tested
To demonstrate the bioequivalence of saxagliptin and metformin in a saxagli...
Status
Completed
Location
Local Institution
Start Date
2011-06
Trial ID
NCT01365091